Original Research
Accepted on 13 May 2025
Cost-effectiveness analysis of first-line Tislelizumab plus chemotherapy for extensive-stage small cell lung cancer from the perspective of the healthcare system in China
in Health Economics
Original Research
Accepted on 13 May 2025
in Health Economics
Original Research
Accepted on 13 May 2025
in Microorganisms in Vertebrate Digestive Systems
Original Research
Accepted on 13 May 2025
in Pediatric Surgery
Original Research
Accepted on 13 May 2025
in Pharmacoepidemiology
Original Research
Accepted on 13 May 2025
in Public Health Policy
Original Research
Accepted on 13 May 2025
in Adolescent and Young Adult Psychiatry
Original Research
Accepted on 13 May 2025
in Substance Use Disorders and Behavioral Addictions
Original Research
Accepted on 13 May 2025
in Environmental Health and Exposome
Original Research
Accepted on 13 May 2025
in Disaster and Emergency Medicine
Community Case Study
Accepted on 13 May 2025
in Public Health Policy
Original Research
Accepted on 13 May 2025
in Substance Use Disorders and Behavioral Addictions
Review
Accepted on 13 May 2025
in T Cell Biology
Case Report
Accepted on 13 May 2025
in Veterinary Neurology and Neurosurgery
Original Research
Accepted on 13 May 2025
in Veterinary Neurology and Neurosurgery
Original Research
Accepted on 13 May 2025
in Inflammation
Original Research
Accepted on 13 May 2025
in Statistical and Computational Physics